Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Aug 30;3(5982):511–513. doi: 10.1136/bmj.3.5982.511

Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.

F R Ellis, I M Clarke, M Modgill, S Currie, D G Harriman
PMCID: PMC1674333  PMID: 1164612

Abstract

Evidence is presented that serum creatinine phosphokinase (CPK) activity is of no direct value in screening patients for susceptibility to malignant hyperpyrexia and does not correlate with halothane-induced muscle contracture or the presence of myopathy. Widely differing CPK values were found at different times in the same people. In most "malignant hyperpyrexia" families the susceptible patients had either normal or inconsistently raised CPK values.

Full text

PDF
511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britt B. A., Kalow W. Malignant hyperthermia: a statistical review. Can Anaesth Soc J. 1970 Jul;17(4):293–315. doi: 10.1007/BF03004694. [DOI] [PubMed] [Google Scholar]
  2. Harriman D. G., Sumner D. W., Ellis F. R. Malignant hyperpyrexia myopathy. Q J Med. 1973 Oct;42(168):639–664. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES